Prognostic Significance of PD-L1 in Patients with Non–Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases-Reference-Cited by-同舟云学术

Prognostic Significance of PD-L1 in Patients with Non–Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases

Published:2016-07 Issue:7 Volume:11 Page:1003-1011
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sun Jong-Mu,Zhou Wei,Choi Yoon-La,Choi So-Jung,Kim Se Eun,Wang Zhen,Dolled-Filhart Marisa,Emancipator Kenneth,Wu Dianna,Weiner Russell,Frisman D.,Kim Hong Kwan,Choi Yong Soo,Shim Young Mog,Kim Jhingook

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N Engl J Med,2012

3. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

4. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N Engl J Med,2013

5. A phase Ib study of MK-3475 in patients with human papillomavirus (HPV)-associated and non-HPV-associated head and neck (H/N) cancer;Seiwert;J Clin Oncol,2014

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of PD-L1 expression on the efficacy of first-line crizotinib in advanced ROS1-rearranged NSCLC;Lung Cancer;2024-08

2. Nonlinear association between PD-L1 expression levels and the risk of postoperative recurrence in non-small cell lung cancer;Scientific Reports;2024-07-04

3. Machine learning identifies prognostic subtypes of the tumor microenvironment of NSCLC;Scientific Reports;2024-07-01

4. Heterogeneity in PD-L1 expression between primary and metastatic lymph nodes: a predictor of EGFR-TKI therapy response in non-small cell lung cancer;Respiratory Research;2024-06-05

5. Prognostic significance of immunotherapy in postoperative recurrent non-small cell lung cancer without EGFR mutations or ALK rearrangements;Journal of Thoracic Disease;2024-06